search again

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Nationwide rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $602,560 · 10th–90th $0$1,380,3840%20%10th90th$602,560Professionalmedian $562,341 · 10th–90th $512,861$676,0830%50%10th90th$562,341$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$870,963.59
Typical High
$1,548,816.62
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.03
Typical High
$660,693.45
BCBS
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$707,945.78
Cigna
Setting
Facility
Modifier
Global
Typical Low
$776,247.12
Median
$1,445,439.77
Typical High
$1,737,800.83
Cigna
Setting
Professional
Modifier
Global
Typical Low
$524,807.46
Median
$616,595.00
Typical High
$707,945.78
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$933,254.30
United
Setting
Professional
Modifier
Global
Typical Low
$407,380.28
Median
$512,861.38
Typical High
$891,250.94